Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today

Clinical trials have reshaped multidisciplinary treatment paradigms for early-stage disease. Is your clinic up to date? Credit available for this activity expires: 7/15/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001332?ecd=bdc_podcast_libsyn_mscpedu